Cleared Traditional

K131094 - VIMOVE

K131094 is an FDA 510(k) clearance for VIMOVE, manufactured by Dorsa VI Pty., Ltd.. The device is a Class 2 Neurology device with product code IKN cleared through the Traditional 510(k) pathway after a 449-day FDA review.

K131094 · Dorsa VI Pty., Ltd. · Neurology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jul 2014
Decision
449d
Days
Class 2
Risk

K131094 is an FDA 510(k) clearance for the VIMOVE. Classified as Electromyograph, Diagnostic (product code IKN), Class II - Special Controls.

Submitted by Dorsa VI Pty., Ltd. (Chalotte, US). The FDA issued a Cleared decision on July 11, 2014 after a review of 449 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 890.1375 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Neurology submissions.

FDA 510(k) Submission Details - K131094

510(k) Number K131094 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 18, 2013
Decision Date July 11, 2014
Days to Decision 449 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
300d slower than avg
Panel avg: 149d · This submission: 449d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

IKN Device Classification - Class 2, Special Controls

Product Code IKN Electromyograph, Diagnostic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 890.1375
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - IKN Electromyograph, Diagnostic

All 57
Devices cleared under the same product code (IKN) and FDA review panel - the closest regulatory comparables to K131094.
ViMove2
K163150 · Dorsavi, Ltd. · Jul 2017
Cadwell Sierra Summit, Cadwell Sierra Ascent
K162383 · Cadwell Industries, Inc. · Mar 2017
ViMove
K142494 · Dorsavi, Ltd. · May 2015
PHYSICAL MONITORING REGISTRATION UNIT-S (PMRU-S)
K123902 · Oktx, LLC · Sep 2013
MYOVISION 3.0 WIREFREE SYSTEM
K123399 · Precision Biometrics, Inc. · Aug 2013
CMAP PRO
K113074 · Medical Technologies, Inc. · Feb 2012
K131094 · VIMOVE
Download PDF FDA Summary Dorsa VI Pty., Ltd.